| Biography:
Baldassare (Baldo) Vinti is a senior counsel in the Litigation and Dispute Resolution Department and member of the Patent Law and Intellectual Property Groups at Proskauer Rose LLP. He is resident in the firm’s New York office.
Baldo’s practice focuses on litigating patent, trademark, trade secret and contractual matters in federal and state courts and before the International Trade Commission. He is a skilled intellectual property litigator with extensive experience in all aspects of litigation, including trials (jury and bench), Markman hearings, appeals before the Federal Circuit, case preparation and strategy, discovery depositions, motion practice, and settlement negotiations. In the area of patent litigation, he has worked on cases involving a broad range of technologies, including immunoassays, orthotics and prosthetics, proton pump inhibitor pharmaceuticals, wound dressings, pharmaceutical capsules, bar code scanning, irrigation equipment, waste management systems, laser inscription devices, and various forms of medical device technology. Baldo has represented numerous major corporations in patent infringement litigations, including Church & Dwight Co.; Inc., Ossur North America Inc.; PSC Inc.; and Netafim Irrigation Inc.
Baldo also regularly handles transactional work, including intellectual property due diligence, intellectual property licensing, structural transactions involving intellectual property, patentability studies, infringement/non-infringement opinions, and client counseling in patent and trademark matters. He has experience in patent and trademark prosecution matters, and is registered to practice before the U.S. Patent and Trademark Office.
Baldo obtained his Juris Doctor degree, cum laude, from St. John's University School of Law and his Bachelor of Science degree in pharmacy also from St. John's University. While in law school, Baldo interned for the Honorable John E. Sprizzo in the United States District Court, Southern District of New York. He also interned for the Honorable Charles A. LaTorella in New York Supreme Court.
Baldo is admitted to the New York and New Jersey Bars, registered to practice before the U.S. Patent and Trademark Office, and admitted to practice before various district courts and the U.S. Court of Appeals for the Federal Circuit. He is also a member of the American Bar Association, New York Intellectual Property Association, Intellectual Property Owners Association’s Litigation Subcommittee, and Intellectual Property Owners Association’s Licensing Subcommittee.
Representative Patent Litigation Matters
Church & Dwight Co., Inc. v. Abbott Laboratories (D.N.J.)
Represented Church & Dwight, Co., Inc. (“Church & Dwight”) in a patent infringement action against Abbott Laboratories relating to over-the-counter pregnancy tests, resulting in a $14.6 million jury verdict and a finding of willful infringement.
Portfolio Technologies, Inc. v. Church & Dwight Co., Inc. (ITC)
Successfully defended Church & Dwight’s particular prophylactic design marketed under the Trojan® brand name in the U.S. International Trade Commission (“ITC”). The ITC ruled in favor of Church & Dwight on a patent challenge mounted by plaintiff Portfolio Technologies, Inc., which alleged that Church & Dwight had infringed plaintiff’s patent.
Pfizer, Inc., Warner-Lambert Co. and Warner-Lambert Co, LLC v. Ajix, Inc. (d/b/a Farmacapsulas S.A.) (D. Ct.)
Successfully defended Ajix, Inc., distributor of hard gelatin capsules, against Pfizer, Inc. Pfizer sued Ajix alleging that its gelatin capsules infringed a Pfizer patent related to intricate locking mechanisms present on the capsules. Obtained a summary judgment of noninfringement of Pfizer's patent, which was summarily affirmed by the Federal Circuit, per curiam.
Church & Dwight Co., Inc. v. Pfizer, Inc.; Church & Dwight Co., Inc. v. Quidel Corporation; and Inverness Medical Switzerland GmbH, Unipath Diagnostics, Inc., and Church & Dwight Co., Inc. v. Acon Laboratories, Inc. (D.N.J., S.D. Cal., D. Mass.)
Represented Church & Dwight in three additional litigations involving patents relating to lateral flow immunoassays. All actions were settled successfully, one for a publicly reported settlement of $18 million. Another was settled following summary judgment of infringement followed by a jury verdict of validity.
Ossur North America, et al. v. Freedom Innovations, et al. (C.D. Cal.)
Obtained a favorable settlement in representing Ossur North America, et al., a leading manufacturer of orthotics and prosthetic devices, in separately filed patent infringement and unfair competition actions respecting prosthetic devices.
Molnlycke Health Care AB et al. v. Medline Industries, Inc., Ossur N. Am. Inc. (N.D. Ga.)
Currently defending Ossur North America in a patent litigation brought by Molnlycke Health Care AB involving wound care products.
Symbol Technologies, Inc. v. PSC Scanning Systems (W.D.N.Y., E.D.N.Y.)
Successfully represented PSC Scanning, Inc. in two patent infringement actions filed, one involving a preliminary injunction and Markman hearing leading to settlement.
|
